POAG
Showing 1 - 25 of 272
POAG Trial (Eagle)
Not yet recruiting
- POAG
- Eagle
- (no location specified)
Jun 5, 2023
Primary Open Angle Glaucoma (POAG), Primary Open Angle Glaucoma of Both Eyes, Primary Open-Angle Glaucoma, Unspecified Eye Trial
Not yet recruiting
- Primary Open Angle Glaucoma (POAG)
- +3 more
- Experimental: QLS-111 ophthalmic solution, (0.015%)
- +4 more
- (no location specified)
Aug 30, 2023
Glaucoma, Primary Open Angle Trial (ELIOS Procedure)
Not yet recruiting
- Glaucoma, Primary Open Angle
- ELIOS Procedure
- (no location specified)
Aug 16, 2023
Primary Open-angle Glaucoma, Cataract Trial in Colchester (Phacoemulsification combined with minimally invasive glaucoma surgery
Not yet recruiting
- Primary Open-angle Glaucoma
- Cataract
- Phacoemulsification combined with minimally invasive glaucoma surgery (MIGS)
-
Colchester, Essex, United KingdomEast Suffolk and North Essex NHS Foundation Trust - Colchester G
Jun 22, 2022
Primary Open-angle Glaucoma Trial in Germany (ARGOS-IO Sensor Pressure System)
Completed
- Primary Open-angle Glaucoma
- ARGOS-IO Sensor Pressure System
-
Aachen, Germany
- +3 more
Jul 11, 2022
Role of Peripheral Vision in Scene Perception (PERISCE)
Not yet recruiting
- Primary Open-angle Glaucoma (POAG)
- Psychophysical evaluation
- (no location specified)
Sep 13, 2022
POAG Trial (Canaloplasty Device)
Not yet recruiting
- POAG
- Canaloplasty Device
- (no location specified)
Jan 13, 2023
Asia Glaucoma Registry
Active, not recruiting
- POAG
-
Hong Kong, Hong KongLeung Kai Shun
Mar 3, 2022
Glaucoma, Primary Open Angle, Ocular Blood Flow, Optical Coherence Tomography Angiography Trial in Fayoum (Brimonidine tartrate
Completed
- Glaucoma, Primary Open Angle
- +2 more
- Brimonidine tartrate 0.2% ophthalmic solution
-
Fayoum, EgyptFayoum University Hospitals
Jul 23, 2022
Glaucoma Open-Angle Primary, Ocular Hypertension Trial in Albany (H-1337 0.6%, H-1337 1.0%, H-1337 Placebo)
Not yet recruiting
- Glaucoma Open-Angle Primary
- Ocular Hypertension
- H-1337 0.6%
- +3 more
-
Albany, GeorgiaDixon Eye Care
Jun 12, 2023
Glaucoma, Glaucoma, Open-Angle Trial (iStent Infinite, Competitor Device)
Recruiting
- Glaucoma
- Glaucoma, Open-Angle
- iStent Infinite
- Competitor Device
-
Montréal, Qubec, CanadaGlaukos Investigator Sites
Dec 7, 2022
Primary Open Angle Glaucoma of Both Eyes Trial in Kazan (Dorzotimol eye drops, 20 mg/mL + 5 mg/mL, Cosopt eye drops, 20 mg/mL +
Completed
- Primary Open Angle Glaucoma of Both Eyes
- Dorzotimol eye drops, 20 mg/mL + 5 mg/mL
- Cosopt eye drops, 20 mg/mL + 5 mg/mL
-
Kazan, Russian FederationRepublican Clinical Ophthalmological Hospital of the Ministry of
Jul 26, 2023
Primary Open Angle Glaucoma (POAG) Trial in Yerevan (iStent)
Completed
- Primary Open Angle Glaucoma (POAG)
- iStent
-
Yerevan, ArmeniaS.V. Malayan's Ophthalmology Centre
Aug 29, 2022
iStent Inject and Inject W in Management of Primary Open-angle
Recruiting
- POAG
- MIGS
- cataract operation and istent
- cataract operation only
-
Amiens, FranceCHU Amiens Nord
Oct 8, 2021
Vivity in Patients With Well Controlled Glaucoma
Recruiting
- Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
- Vivity Extended Depth of Focus
-
Montréal, Quebec, CanadaClinique Bellevue
Sep 29, 2021
Primary Open-angle Glaucoma (POAG), Ocular Hypertension Trial in Lexington (SHP639 (n=60), Placebo Comparator (n=24))
Completed
- Primary Open-angle Glaucoma (POAG)
- Ocular Hypertension
- SHP639 (n=60)
- Placebo Comparator (n=24)
-
Lexington, MassachusettsCentral Contact
May 15, 2021
Glaucoma, Open-Angle, Ocular Hypertension Trial in Monterrey (Dorzolamide-timolol-brimonidine and latanoprost,
Recruiting
- Glaucoma, Open-Angle
- Ocular Hypertension
- Dorzolamide-timolol-brimonidine and latanoprost
- Dorzolamide-timolol and latanoprost
-
Monterrey, MexicoServicios Médicos y de Investigación Clínica InspirePharma S. de
Dec 22, 2021
Normal Tension Glaucoma, Primary Open-angle Glaucoma, Glaucoma, Suspect Trial in Seongnam-si, Seoul (Eybelis ophthalmic solution
Recruiting
- Normal Tension Glaucoma
- +3 more
- Eybelis ophthalmic solution 0.002%
-
Seongnam-si, Korea, Republic of
- +7 more
Mar 6, 2022
Open Angle Glaucoma, Ocular Hypertension Trial in Israel, Italy, United Kingdom (Direct Selective Trabeculoplasty, Selective
Recruiting
- Open Angle Glaucoma
- Ocular Hypertension
- Direct Selective Trabeculoplasty
- Selective Trabeculoplasty
-
Be'er Sheva, Israel
- +7 more
Aug 30, 2021
Primary Open Angle Glaucoma, Ocular Hypertension Trial in Setagaya-Ku (Netarsudil ophthalmic solution 0.02%, Ripasudil HCl
Completed
- Primary Open Angle Glaucoma
- Ocular Hypertension
- Netarsudil ophthalmic solution 0.02%
- Ripasudil hydrochloride hydrate ophthalmic solution 0.4%
-
Setagaya-Ku, Tokyo, JapanSeijo Clinic
Aug 29, 2021
Glaucoma, Ocular Hypertension Trial in Japan (Xalatan, Xalacom)
Completed
- Glaucoma
- Ocular Hypertension
-
Ichinomiya, Aichi, Japan
- +53 more
Aug 16, 2021
Glaucoma, Primary Open Angle Glaucoma, Pseudoexfoliation Glaucoma Trial in Vienna (Changes in Ocular rigidity)
Completed
- Glaucoma
- +2 more
- Changes in Ocular rigidity
-
Vienna, AustriaDepartment of Clinical Pharmacology, Medical University of Vienn
Feb 19, 2020
Primary Open-angle Glaucoma (POAG) Patient Trial in New York (SENSIMED Triggerfish®)
Terminated
- Primary Open-angle Glaucoma (POAG) Patient
- SENSIMED Triggerfish®
-
New York, New YorkThe New York Eye and Ear Infirmary
Sep 15, 2020
Latanoprost , Travoprost and Tafluprost in Reducing IOP
Completed
- Primary Open Angle Glaucoma
- Latanoprost 0.005% Ophthalmic Solution
- +2 more
-
Cairo, EgyptKasr El-Aini hospital
Jul 3, 2020